Professor Colin Palmer is Associate Dean, Research & Chair of Pharmacogenomics at the School of Medicine. His laboratory specializes in population genetic research and has research projects studying the genetic basis for susceptibility to common diseases such as type 2 diabetes, heart disease, asthma and cancer. He has published over 170 papers in top journals including papers in Science, Nature, Nature Genetics and the New England Medical Journal. These papers have been cited by over 10,000 other studies worldwide. Current studies involve using the electronic medical register to link patient outcome to genomic information, including GWAS and next generation sequencing data. This will provide new drug targets for the prevention and treatment of such diseases and will also allow for more informed and personalised usage of current therapies.
